Home › Therapeutic areas › Cardiovascular › Heart Failure

Heart Failure (3 companies)

Companies with an active program in Heart Failure.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
CRDL Cardiol Therapeutics Cardiovascular Rare 2 Phase 3 $124M 4
EWTX Edgewise Therapeutics Cardiovascular 1 Phase 2 $4.60B 3
MESO Mesoblast CardiovascularGI/Hepatology+2 Rare 1 Approved $1.54B 5